CYP7A1 and metabolic disease: some studies suggest that pro-inflammatory cytokines IL-1β and TNF-α suppress the expression of CYP7A1 and NTCP, leading to decreased BA synthesis and a reduction in the hepatic-enterohepatic circulation rate, thereby contributing to BA metabolic disorders.